(Q52973062)
Statements
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. (English)
1 reference
Scheibenbogen C
1 reference
Schmittel A
1 reference
Keilholz U
1 reference
Allgäuer T
1 reference
Hofmann U
1 reference
Max R
1 reference
Thiel E
1 reference
Schadendorf D
1 reference
1 March 2000
1 reference
23
1 reference
275-281
1 reference
2
1 reference
Identifiers
1 reference